Immunonutrition in the critically ill: A systematic review of clinical outcome
- 1 December 1999
- journal article
- research article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 27 (12) , 2799-2805
- https://doi.org/10.1097/00003246-199912000-00032
Abstract
To perform a meta-analysis addressing whether enteral nutrition with immune-enhancing feeds benefits critically ill patients after trauma, sepsis, or major surgery. Studies were identified by MEDLINE search (1967 to January 1998) for original articles in English using the search terms "human," "enteral nutrition," "arginine," "nucleotides," "omega-3 fatty acids," "immunonutrition," "IMPACT," and "Immun-Aid." Additionally, the authors of the studies and the manufacturers of the feeds were contacted for additional information. Access to original databases was obtained for the three largest studies. Fifteen randomized controlled trials comparing patients receiving standard enteral nutrition with patients receiving a commercially available immune-enhancing feed with arginine with or without glutamine, nucleotides, and omega-3 fatty acids were identified by two independent reviewers (Dr. Beale and Dr. Bryg). Descriptive and outcome data were extracted independently from the papers by the same two reviewers, one of whom (Dr. Bryg) analyzed the original databases. Three studies were excluded from analysis, leaving 12 studies containing 1,557 subjects, 1,482 of whom were analyzed. Main outcome measures were mortality, infection, ventilator days, intensive care unit stay, hospital stay, diarrhea days, calorie intake, and nitrogen intake. The meta-analysis was performed on an intent-to-treat basis. There was no effect of immunonutrition on mortality (relative risk = 1.05, confidence interval [CI] = 0.78, 1.41; p = .76). There were significant reductions in infection rate (relative risk = 0.67, CI = 0.50, 0.89; p = .006), ventilator days (2.6 days, CI = 0.1, 5.1; p = .04), and hospital length of stay (2.9 days, CI = 1.4, 4.4; p = .0002) in the immunonutrition group. The benefits of enteral immunonutrition were most pronounced in surgical patients, although they were present in all groups. The reduction in hospital length of stay and infections has resource implications.Keywords
This publication has 19 references indexed in Scilit:
- Influence of arginine, omega-3 fatty acids and nucleotide-supplemented enteral support on systemic inflammatory response syndrome and multiple organ failure in patients after severe traumaNutrition, 1998
- Artificial nutrition after major abdominal surgeryCritical Care Medicine, 1998
- Early postoperative enteral immunonutritionCritical Care Medicine, 1997
- A Randomized Trial of Isonitrogenous Enteral Diets After Severe TraumaAnnals of Surgery, 1996
- Clinical outcome and immunology of postoperative arginine, ω-3 fatty acids, and nucleotide-enriched enteral feeding: A randomized prospective comparison with standard enteral and low calorie/low fat IV solutionsNutrition, 1996
- Enteral Nutrition During Multimodality Therapy in Upper Gastrointestinal Cancer PatientsAnnals of Surgery, 1995
- Early enteral administration of a formula (Impact Registered Trademark) supplemented with arginine, nucleotides, and fish oil in intensive care unit patientsCritical Care Medicine, 1995
- CLINICAL BENEFITS OF AN IMMUNE-ENHANCING DIET FOR EARLY POSTINJURY ENTERAL FEEDINGPublished by Wolters Kluwer Health ,1994
- Does the formulation of enteral feeding products influence infectious morbidity and mortality rates in the critically ill patient? A critical review of the evidenceCritical Care Medicine, 1994
- Enteral nutrition in the critically ill patient: A critical review of the evidenceIntensive Care Medicine, 1993